US20030017620A1 - Lyophilization of colloidal metals for surface enhanced Raman scattering - Google Patents

Lyophilization of colloidal metals for surface enhanced Raman scattering Download PDF

Info

Publication number
US20030017620A1
US20030017620A1 US10/177,194 US17719402A US2003017620A1 US 20030017620 A1 US20030017620 A1 US 20030017620A1 US 17719402 A US17719402 A US 17719402A US 2003017620 A1 US2003017620 A1 US 2003017620A1
Authority
US
United States
Prior art keywords
container
metal
assay
pretreatment
assay system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/177,194
Inventor
Keith Carron
Bryan Ray
Roberta Sulk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Wyoming
Original Assignee
University of Wyoming
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Wyoming filed Critical University of Wyoming
Priority to US10/177,194 priority Critical patent/US20030017620A1/en
Assigned to WYOMING, UNIVERSITY OF reassignment WYOMING, UNIVERSITY OF ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: RAY, BRYAN HUBERT, CARRON, KEITH T., KELLY, KIRSE, SULK, ROBERTA A.
Publication of US20030017620A1 publication Critical patent/US20030017620A1/en
Priority to US13/160,985 priority patent/US9097675B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/65Raman scattering
    • G01N21/658Raman scattering enhancement Raman, e.g. surface plasmons
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54373Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation

Definitions

  • This invention relates to Raman spectroscopy and Surface Enhanced Raman Scattering (SERS). More specifically, this invention relates to a stable form of colloidal metal particles that when reconstituted, produces a SERS active solution.
  • Raman spectroscopy stems from the inelastic scattering of light by molecular vibrational energy levels.
  • Raman spectroscopy as an analytical tool has been known for decades, and is particularly popular for several reasons.
  • molecular composition can be determined in the presence of water.
  • Visible light can be employed for analysis allowing for the use of conventional fiber optics.
  • Unique spectral fingerprints allow for identification and quantification of a wide variety of solids, liquids, and gases.
  • One of the significant disadvantages of Raman spectroscopy is the inadequate sensitivity for trace or ultratrace analysis. This stems from the inherently weak nature of Raman scattering.
  • a method to overcome the lack of adsorptivity to SERS surfaces by an analyte is to provide surface coatings that have an affinity for the analyte.
  • An example is an early publication which describes using a surface bound coating in the detection of hydrogen ions at a surface using SERS (Determination of pH with SERS Fiber Optic Probes. Ken I. Mullen, DaoXin Wang, L. Gayle Hurley, and Keith Carron Anal. Chem., 64, 930, 1992). This publication showed that it was possible to permanently attach a coating to a SERS surface and to have the coating provide the affinity for the analyte.
  • an irreversible covalent bonding reagent could be used to achieve even more sensitive detection.
  • the surface need not be coated with the surface bound reagent, but rather, the reagent could have two reactive sites. One site is analyte specific and the other is surface binding specific. This produces a high affinity permanent bond to the analyte and a high affinity permanent bond to the surface.
  • a dual binding reagent for trace detection is a reagent that binds bilirubin and which has an argentiphillic sulfide group to bind to silver (Surface Enhanced Raman Assays (SERA): Measurement of Bilirubin and Salicylate, Roberta Sulk, Collin Chan, Jason Guicheteau, Cieline Gomez, J. B. B. Heyns, Robert Corcoran, and Keith Carron, J. Raman Spectrosc., 1999, 30, 853-859).
  • SERA Surface Enhanced Raman Assays
  • an assay is needed which is capable of producing a SERS active solution that is sensitive to a specific analyte or group of analytes.
  • the assay comprises lyophilized colloidal particles of a metal, which have been lyophilized.
  • the lyophilized particles of metal produce a SERS active solution when reconstituted.
  • the assay system comprises a container with lyophilized colloidal particles of a metal disposed in a first section thereof.
  • the lyophilized colloidal particles of a metal contained in the container produce a SERS active solution when reconstituted.
  • a method of analyzing a material comprises the steps of: providing a container; placing colloidal particles of a metal in a first section of the container; lyophilizing the colloidal particles of the metal to produce an assay; simultaneously reconstituting and mixing the assay with the material to be analyzed to produce a SERS active solution; performing SERS spectroscopy on the SERS active solution.
  • FIG. 1A is a spectrum of reactive blue (RB) 15 dye in fresh colloid suspension.
  • FIG. 1B is a spectrum of a RB 15 dye with reconstituted lyophilized colloidal suspension.
  • FIG. 2A is a spectrum of a Partial Least Squares (PLS) correlation model using a reconstituted lyophilized colloid and RB 15 dye.
  • PLS Partial Least Squares
  • FIG. 2B is a correlation plot between actual concentration and predicted concentration for a reconstituted lyophilized colloid and RB 15 dye solution.
  • FIG. 3A is a spectrum of a Partial Least Squares (PLS) correlation model using a reconstituted lyophilized colloid with 0.05% w/w polyethylene glycol (PEG) and RB 15 dye.
  • PLS Partial Least Squares
  • FIG. 3B is a schematic representation of an exemplary apparatus used for producing the lyophilized, colloidal noble metal particles and PEG according to the present invention.
  • FIG. 3C is a correlation plot between actual concentration and predicted concentration for a reconstituted lyophilized colloid solution with 0.05% w/w PEG and RB 15 dye.
  • FIG. 4A is a spectrum of a Partial Least Squares (PLS) correlation model using a reconstituted lyophilized colloid with 0.05% PEG, RB 15 dye, and a reagent of Analyte Reactive Coating soluble in Water (ARCW).
  • PLS Partial Least Squares
  • FIG. 4B is a diagrammatic representation of the chemical structure of the Analyte Reactive Coating soluble in Water (ARCW).
  • FIG. 4C is a correlation plot between actual concentration and predicted concentration for a reconstituted lyophilized colloid solution with 0.05% w/w PEG and RB 15 dye and a reagent of ARCW.
  • FIGS. 5 and 6 are PLS cross-validation plots of actual versus predicted hGH concentration levels for a Surface Enhanced Raman ImmunoAssay (SERIA) analysis using a lyophilized silver colloidal base according to the present invention.
  • SERIA Surface Enhanced Raman ImmunoAssay
  • FIG. 7 is a schematic representation of an assay system according to a first illustrative embodiment of the present invention using lyophilized colloids.
  • FIG. 8 is a schematic representation of an assay system according to a second illustrative embodiment of the present invention using lyophilized colloids.
  • One aspect of the present invention includes an assay and an assay system for use in Surface Enhanced Raman Scattering (SERS) spectroscopy. Another aspect of the present invention includes methods for preparing the assay and assay system. Still another aspect of the present invention includes a method of analyzing a material using the assay system of the present invention and SERS spectroscopy. Another aspect of the present invention includes a method of analyzing a material using the assay system of the present invention and Surface Enhanced Raman ImmunoAssay (SERIA).
  • SERIA Surface Enhanced Raman ImmunoAssay
  • the assay of the present invention comprises a colloidal suspension of noble metal particles, such as silver, gold, or copper particles, which have been lyophilized to dryness using conventional lyophilizing techniques.
  • the lyophilized, colloidal particles of the present invention have long term stability, i.e., the colloidal particles can be stored for a long period of time, and are sensitive to a specific analyte or group of analytes.
  • the lyophilized, colloidal noble metal particles of the present invention produce a SERS active solution, when reconstituted to a colloidal suspension.
  • a specific advantage of having a SERS active solution is that the SERS phenomenon exhibits a signal from material localized near the particle surface.
  • This phenomenon precludes the need for removing excess analyte, impurity, or reagent, that indicates the presence of an analyte, from the sample mixture.
  • This aspect combined with the aspect of a coated particle with long-term stability makes the assay of the invention commercially important.
  • a particularly important aspect of the assay of the present invention is that the amount of colloidal particles is determined very accurately through a volumetric delivery of a known concentration of colloidal suspension, or delivery of a known mass of colloidal suspension.
  • the mass delivery is enabling to an assay since a large mass of diluted colloid can be used to accurately deliver a small amount of colloid into the chamber of a sample container.
  • the lyophilized, colloidal particle assay of the present invention may further comprise one or more reagents.
  • the type or types of reagents used will depend upon the particular application or sample to be analyzed.
  • the lyophilized, colloidal particle assay may further comprise one or more antibodies, thereby forming a Surface Enhanced Raman ImmunoAssay (SERIA).
  • SERIA Surface Enhanced Raman ImmunoAssay
  • the assay system of the present invention comprises a sample container which contains the lyophilized, colloidal noble metal particles of the present invention.
  • the container typically includes a pretreatment which prevents the lyophilized, colloidal particles from binding to the surface of the chamber of the container, or from binding with each other, thus inhibiting the lyophilized, colloid's ability to be reconstituted to a colloidal suspension.
  • the pretreatment may comprise a wax-like material, such as polyethylene glycol (PEG), or combination of materials, which is applied to the chamber of the container. It should be understood, however, that the pretreatment can be omitted when the sample container is made from a material which possesses the ability to contain the lyophilized, colloid without inhibiting its ability to be reconstituted.
  • a material or combination of materials may be added to the colloidal particles, prior to lyophilization, which also immobilizes the lyophilized, colloidal particles within the container and prevents the colloidal particles from binding to the surface of the chamber of the container, or from binding with each other.
  • This pretreatment may also be omitted.
  • This material may also comprise a wax-like material, such as PEG.
  • PEG polyethylene glycol
  • Another example would be a surfactant material such as sodium dodecylsulfate (SDS).
  • FIG. 7 shows an assay system according to a first illustrative embodiment of the present invention, which enables sequential addition of such reagents to the assay via physical separation of the reagent and colloid.
  • a lyophilized assay reagent 16 is located in a chamber 11 of a tube-style container 10 adjacent to a tapered open end 12 thereof, and a lyophilized, colloidal particle assay 18 of the present invention is in the chamber 11 adjacent to an opposing open end 14 of the container 10 .
  • the assay system of the present invention may also comprise a sample container with multiple sample chambers, which enables multiple assays to be performed in parallel, if desired.
  • FIG. 8 shows an system according to a second illustrative embodiment of the invention constructed as a multiformat assay 40 which forms a Surface Enhanced Raman ImmunoAssay (SERIA) where the lyophilized colloid is treated with antibodies and reconstitution is performed in a microwell plate 42 with added sample and reagents.
  • SERIA Surface Enhanced Raman ImmunoAssay
  • the microwell plate 42 includes a plurality of wells 44 containing identical lyophilized colloidal particles 46 (colloidal solid) treated with one or more antibodies for analyzing multiple assays at one time.
  • Each lyophilized colloidal solid 46 is reconstituted to a SERS active colloidal solution by the reagent liquids of the assay.
  • the sample chamber or chambers include closures, e.g. Critoseal 17 (FIG. 7), which are used for sealing the chambers after introduction of a sample, to prevent contamination of the sample or more importantly, to prevent potential spread of the sample, which may be hazardous to testing personnel or the test facility.
  • closures e.g. Critoseal 17 (FIG. 7)
  • FIG. 1A is a spectrum of reactive blue (RB) 15 dye in fresh colloid suspension having a pH of 6.8. Ten milliliters of this colloid was lyophilized to dryness using conventional lyophilization techniques. The leftover powder was dark gray and very light and susceptible to air currents. The gray powder was then reconstituted with 10 ml of H 2 O and 2 ⁇ L of an aqueous 1% sodium hydrogen carbonate solution was added to raise the pH from 5.7 to that of the fresh colloid (6.8). Note that no polyethylene glycol (PEG) was added to the reconstituted colloid.
  • PEG polyethylene glycol
  • FIG. 1B is a spectrum of this reconstituted colloidal suspension with RB 15 dye.
  • FIG. 2A represents a spectrum of a Partial Least Squares (PLS) correlation model obtained from running a concentration curve of a reconstituted colloid and RB 15 dye.
  • a stock RB 15 solution was prepared by dissolving 0.01283 grams of RB 15 into 10 ml Millipore H 2 O. Concentrations were prepared from the stock solution ranging from 1.0-6.18 ⁇ 10 ⁇ 6 M RB 15 using Millipore H 2 O.
  • the reconstituted colloid 200 ⁇ L was placed into separate 1 ml auto sampler vials. A 20 ⁇ L aliquot of each of the RB 15 concentrations was added to separate vials filled with reconstituted colloid.
  • the lyophilized colloid is a very fine powder that is very susceptible to air currents. Accordingly, in the discussion which follows, polyethylene glycol (PEG) 900 will be introduced into the lyophilizing process to alleviate problems with containing the fine powder and preventing the lyophilized colloidal particles from sticking to the surface of a container.
  • PEG polyethylene glycol
  • FIG. 3A represents a spectrum of a PLS correlation model using 0.05% w/w PEG 900 m.w./colloid and RB 15 dye.
  • PEG 900 was diluted to 4.00 g with colloid.
  • a 370 ⁇ L Caraway blood collecting tube was submerged into liquid nitrogen until the nitrogen ceases to boil then 100 ⁇ L of the solution was injected into the frozen tube.
  • Approximately 40 tubes can be prepared from 4.00 g of PEG 900/colloid solution.
  • the tubes, denoted by numeral 30 were placed in a high vacuum vial 32 with a stopper 33 purchased from Labconco.
  • the vial 32 and stopper 33 was placed in a Styrofoam cooler 34 packed in dry ice and attached to a lyophilizer (not shown), via a steel tube 36 which extends through the stopper, for 24 hours.
  • a stock solution of 10.0 ⁇ 10 ⁇ 6 M RB 15 was prepared.
  • a range of concentrations from 1.0-10.0 ⁇ 10 ⁇ 6 M RB 15 was prepared by diluting with Millipore H 2 O.
  • 100 ⁇ L of each concentration of RB 15 was injected and a 0.5 ⁇ 5 mm Teflon coated rod was inserted into each tube. A magnet was used to stir the solution with the rod until the lyophilized colloid was completely dissolved, this taking approximately 2 min.
  • FIG. 4B shows a reagent of Analyte Reactive Coating soluble in Water (ARCW).
  • ARCW Analyte Reactive Coating soluble in Water
  • a 2.99 ⁇ 10 ⁇ 4 M stock solution of bilirubin was prepared by dissolving 0.00175 g of bilirubin in a 5:4:1 ethanol, water, saturated bicarbonate solution.
  • a 2.99 ⁇ 10 ⁇ 6 M solution of bilirubin was prepared by diluting with Millipore H 2 O, 100 ⁇ L of the stock solution to 9.8 mL H 2 O+100 ⁇ L 0.05 M KOH.
  • a concentration range 5.98 ⁇ 10 ⁇ 7 to 2.99 ⁇ 10 ⁇ 6 M bilirubin was prepared.
  • 100 ⁇ L of each concentration and a Teflon coated iron rod was added to the end of the tube, which contained the ARCW.
  • FIG. 5 shows a PLS cross-validation plot of actual versus predicted human Growth Hormone (hGH) concentration levels for a Surface Enhanced Raman ImmunoAssay (SERIA) analysis using a lyophilized silver colloidal base.
  • hGH human Growth Hormone
  • SERIA Surface Enhanced Raman ImmunoAssay
  • a mini-microwell plate (NUNC®) was used as the sample container for the analysis.
  • NUNC® A mini-microwell plate
  • To each of 10 wells of the plate was added 20 ⁇ L of the PEG/RhGHAb solution.
  • the plate was placed in liquid nitrogen to ‘flash’ freeze the wells of solution and then placed in a high vacuum vial set in a cooling container of dry ice.
  • the vacuum vial was then attached to the lyophilizer for 24 hr.
  • Each well of lyophilized colloidal base appeared as a light tan colored waxy semi-solid.
  • the addition of liquid immediately reconstituted the base to produce a light tan colored colloidal suspension resembling the original solution.
  • the analysis was completed by the addition of varying concentration of hGH antigen in an aqueous sodium bicarbonate solution (1%), followed by the addition of a reporter molecule solution.
  • the solution of antigen was used to reconstitute the lyophilized PEG/RhGHAb for the assay.
  • FIG. 6 shows a PLS cross-validation plot of actual versus predicted hGH concentration levels for a SERIA analysis similar to that described above.
  • the lyophilized colloidal base was a 0.5% PEG/RhGHAb.
  • the wells of colloidal base appeared as tan colored nugget with a puckered surface. Addition of the antigen solution caused complete reconstitution of the colloidal base.

Abstract

An assay and method of making same for use in SERS spectroscopy. The assay includes colloidal particles of a metal, which have been lyophilized. The lyophilized particles of metal produce a SERS active solution when reconstituted. The lyophilized particles of metal may be provided in a container in an assay system.

Description

  • This application claims the benefit of U.S. Provisional Application No. 60/300,270, filed Jun. 21, 2001.[0001]
  • FIELD OF THE INVENTION
  • This invention relates to Raman spectroscopy and Surface Enhanced Raman Scattering (SERS). More specifically, this invention relates to a stable form of colloidal metal particles that when reconstituted, produces a SERS active solution. [0002]
  • BACKGROUND OF INVENTION
  • Raman spectroscopy stems from the inelastic scattering of light by molecular vibrational energy levels. Raman spectroscopy as an analytical tool has been known for decades, and is particularly popular for several reasons. For example, molecular composition can be determined in the presence of water. Visible light can be employed for analysis allowing for the use of conventional fiber optics. Unique spectral fingerprints allow for identification and quantification of a wide variety of solids, liquids, and gases. One of the significant disadvantages of Raman spectroscopy is the inadequate sensitivity for trace or ultratrace analysis. This stems from the inherently weak nature of Raman scattering. [0003]
  • In the early 1970s several researchers found an anomalous enhancement of Raman scattering at the surface of certain metals. It has subsequently been found that the metals that have both practicality and strong enhancing properties are silver, gold, and copper. The enhancement is believed to generally come from an electromagnetic effect and in some cases, an enhancement due to the nature of the chemical bond to the metal surface has also been found. The reported enhancement for SERS depends on the structure of the surface and ranges from about 105 to 108. This discovery immediately made it possible to detect very small amounts of material adsorbed to these surfaces. The SERS effect is limited to molecules attached to or in very close proximity with the surface. [0004]
  • The drawback to conventional SERS is that it is limited to analytes that will naturally adsorb to a SERS active metal surface. Thus, while in special cases SERS provides sensitive detection, in most cases it suffers from the inability of the molecule to adsorb to the surface and to benefit from the SERS effect. [0005]
  • A method to overcome the lack of adsorptivity to SERS surfaces by an analyte, is to provide surface coatings that have an affinity for the analyte. An example is an early publication which describes using a surface bound coating in the detection of hydrogen ions at a surface using SERS (Determination of pH with SERS Fiber Optic Probes. Ken I. Mullen, DaoXin Wang, L. Gayle Hurley, and Keith Carron [0006] Anal. Chem., 64, 930, 1992). This publication showed that it was possible to permanently attach a coating to a SERS surface and to have the coating provide the affinity for the analyte.
  • More recently, it has been demonstrated that an irreversible covalent bonding reagent could be used to achieve even more sensitive detection. Furthermore, it was shown that the surface need not be coated with the surface bound reagent, but rather, the reagent could have two reactive sites. One site is analyte specific and the other is surface binding specific. This produces a high affinity permanent bond to the analyte and a high affinity permanent bond to the surface. An example of a dual binding reagent for trace detection is a reagent that binds bilirubin and which has an argentiphillic sulfide group to bind to silver (Surface Enhanced Raman Assays (SERA): Measurement of Bilirubin and Salicylate, Roberta Sulk, Collin Chan, Jason Guicheteau, Cieline Gomez, J. B. B. Heyns, Robert Corcoran, and Keith Carron, [0007] J. Raman Spectrosc., 1999, 30, 853-859).
  • Accordingly, an assay is needed which is capable of producing a SERS active solution that is sensitive to a specific analyte or group of analytes. [0008]
  • SUMMARY OF THE INVENTION
  • An assay and method of making same is disclosed herein for use in SERS spectroscopy. The assay comprises lyophilized colloidal particles of a metal, which have been lyophilized. The lyophilized particles of metal produce a SERS active solution when reconstituted. [0009]
  • An assay system and method of making same is further disclosed herein for use in SERS spectroscopy. The assay system comprises a container with lyophilized colloidal particles of a metal disposed in a first section thereof. The lyophilized colloidal particles of a metal contained in the container produce a SERS active solution when reconstituted. [0010]
  • A method of analyzing a material is further disclosed herein. The method comprises the steps of: providing a container; placing colloidal particles of a metal in a first section of the container; lyophilizing the colloidal particles of the metal to produce an assay; simultaneously reconstituting and mixing the assay with the material to be analyzed to produce a SERS active solution; performing SERS spectroscopy on the SERS active solution.[0011]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1A is a spectrum of reactive blue (RB) 15 dye in fresh colloid suspension. [0012]
  • FIG. 1B is a spectrum of a RB 15 dye with reconstituted lyophilized colloidal suspension. [0013]
  • FIG. 2A is a spectrum of a Partial Least Squares (PLS) correlation model using a reconstituted lyophilized colloid and RB 15 dye. [0014]
  • FIG. 2B is a correlation plot between actual concentration and predicted concentration for a reconstituted lyophilized colloid and RB 15 dye solution. [0015]
  • FIG. 3A is a spectrum of a Partial Least Squares (PLS) correlation model using a reconstituted lyophilized colloid with 0.05% w/w polyethylene glycol (PEG) and RB 15 dye. [0016]
  • FIG. 3B is a schematic representation of an exemplary apparatus used for producing the lyophilized, colloidal noble metal particles and PEG according to the present invention. [0017]
  • FIG. 3C is a correlation plot between actual concentration and predicted concentration for a reconstituted lyophilized colloid solution with 0.05% w/w PEG and RB 15 dye. [0018]
  • FIG. 4A is a spectrum of a Partial Least Squares (PLS) correlation model using a reconstituted lyophilized colloid with 0.05% PEG, RB 15 dye, and a reagent of Analyte Reactive Coating soluble in Water (ARCW). [0019]
  • FIG. 4B is a diagrammatic representation of the chemical structure of the Analyte Reactive Coating soluble in Water (ARCW). [0020]
  • FIG. 4C is a correlation plot between actual concentration and predicted concentration for a reconstituted lyophilized colloid solution with 0.05% w/w PEG and RB 15 dye and a reagent of ARCW. [0021]
  • FIGS. 5 and 6 are PLS cross-validation plots of actual versus predicted hGH concentration levels for a Surface Enhanced Raman ImmunoAssay (SERIA) analysis using a lyophilized silver colloidal base according to the present invention. [0022]
  • FIG. 7 is a schematic representation of an assay system according to a first illustrative embodiment of the present invention using lyophilized colloids. [0023]
  • FIG. 8 is a schematic representation of an assay system according to a second illustrative embodiment of the present invention using lyophilized colloids.[0024]
  • DETAILED DESCRIPTION OF THE INVENTION
  • One aspect of the present invention includes an assay and an assay system for use in Surface Enhanced Raman Scattering (SERS) spectroscopy. Another aspect of the present invention includes methods for preparing the assay and assay system. Still another aspect of the present invention includes a method of analyzing a material using the assay system of the present invention and SERS spectroscopy. Another aspect of the present invention includes a method of analyzing a material using the assay system of the present invention and Surface Enhanced Raman ImmunoAssay (SERIA). [0025]
  • The assay of the present invention comprises a colloidal suspension of noble metal particles, such as silver, gold, or copper particles, which have been lyophilized to dryness using conventional lyophilizing techniques. The lyophilized, colloidal particles of the present invention have long term stability, i.e., the colloidal particles can be stored for a long period of time, and are sensitive to a specific analyte or group of analytes. The lyophilized, colloidal noble metal particles of the present invention produce a SERS active solution, when reconstituted to a colloidal suspension. A specific advantage of having a SERS active solution is that the SERS phenomenon exhibits a signal from material localized near the particle surface. This phenomenon precludes the need for removing excess analyte, impurity, or reagent, that indicates the presence of an analyte, from the sample mixture. This aspect combined with the aspect of a coated particle with long-term stability makes the assay of the invention commercially important. [0026]
  • A particularly important aspect of the assay of the present invention is that the amount of colloidal particles is determined very accurately through a volumetric delivery of a known concentration of colloidal suspension, or delivery of a known mass of colloidal suspension. The mass delivery is enabling to an assay since a large mass of diluted colloid can be used to accurately deliver a small amount of colloid into the chamber of a sample container. [0027]
  • The lyophilized, colloidal particle assay of the present invention may further comprise one or more reagents. The type or types of reagents used will depend upon the particular application or sample to be analyzed. Further, the lyophilized, colloidal particle assay may further comprise one or more antibodies, thereby forming a Surface Enhanced Raman ImmunoAssay (SERIA). [0028]
  • The assay system of the present invention comprises a sample container which contains the lyophilized, colloidal noble metal particles of the present invention. The container typically includes a pretreatment which prevents the lyophilized, colloidal particles from binding to the surface of the chamber of the container, or from binding with each other, thus inhibiting the lyophilized, colloid's ability to be reconstituted to a colloidal suspension. The pretreatment may comprise a wax-like material, such as polyethylene glycol (PEG), or combination of materials, which is applied to the chamber of the container. It should be understood, however, that the pretreatment can be omitted when the sample container is made from a material which possesses the ability to contain the lyophilized, colloid without inhibiting its ability to be reconstituted. [0029]
  • In addition or alternative to pretreating the chamber surface(s) of the container, a material or combination of materials may be added to the colloidal particles, prior to lyophilization, which also immobilizes the lyophilized, colloidal particles within the container and prevents the colloidal particles from binding to the surface of the chamber of the container, or from binding with each other. This pretreatment may also be omitted. This material may also comprise a wax-like material, such as PEG. Another example would be a surfactant material such as sodium dodecylsulfate (SDS). In view of the above, it should be apparent that the assay system of the present invention affords long term stability such that a pretreated assay can be provided for a customer for later use. [0030]
  • In certain applications, one or more reagents must be added in sequential fashion to the assay of the present invention. FIG. 7 shows an assay system according to a first illustrative embodiment of the present invention, which enables sequential addition of such reagents to the assay via physical separation of the reagent and colloid. As shown, a [0031] lyophilized assay reagent 16 is located in a chamber 11 of a tube-style container 10 adjacent to a tapered open end 12 thereof, and a lyophilized, colloidal particle assay 18 of the present invention is in the chamber 11 adjacent to an opposing open end 14 of the container 10. This enables one to introduce a sample into the chamber 11 of the container 10 and have it reconstitute and mix with the reagent 16 first by capillary action. Mixing of the sample and reagent is accomplished with a mixing rod 13 disposed in the chamber 11 of the container 10, after which the reagent and sample mixture reconstitutes the lyophilized, colloidal particle assay 18 and mixes therewith. A closure 17, such as a Critoseal, is provided and is inserted in the tapered open end 12 of the container 10 after the sample is collected. It should be understood, that containers of other configurations can be utilized in the assay system of the present invention.
  • Assays are typically performed either individually or multiply. Multiple assays have an advantage that many of the steps involved in the assay can be performed in parallel, thus decreasing the time of the assay. Accordingly, the assay system of the present invention may also comprise a sample container with multiple sample chambers, which enables multiple assays to be performed in parallel, if desired. FIG. 8 shows an system according to a second illustrative embodiment of the invention constructed as a [0032] multiformat assay 40 which forms a Surface Enhanced Raman ImmunoAssay (SERIA) where the lyophilized colloid is treated with antibodies and reconstitution is performed in a microwell plate 42 with added sample and reagents. As shown, the microwell plate 42 includes a plurality of wells 44 containing identical lyophilized colloidal particles 46 (colloidal solid) treated with one or more antibodies for analyzing multiple assays at one time. Each lyophilized colloidal solid 46 is reconstituted to a SERS active colloidal solution by the reagent liquids of the assay.
  • Additionally, as the assay of the present invention takes special advantage of the SERS effect to produce a one-step assay, the sample chamber or chambers include closures, e.g. Critoseal [0033] 17 (FIG. 7), which are used for sealing the chambers after introduction of a sample, to prevent contamination of the sample or more importantly, to prevent potential spread of the sample, which may be hazardous to testing personnel or the test facility.
  • FIGS. 1A and 1B represent the spectral results of an initial study of lyophilized, colloidal noble metal particles. FIG. 1A is a spectrum of reactive blue (RB) 15 dye in fresh colloid suspension having a pH of 6.8. Ten milliliters of this colloid was lyophilized to dryness using conventional lyophilization techniques. The leftover powder was dark gray and very light and susceptible to air currents. The gray powder was then reconstituted with 10 ml of H[0034] 2O and 2 μL of an aqueous 1% sodium hydrogen carbonate solution was added to raise the pH from 5.7 to that of the fresh colloid (6.8). Note that no polyethylene glycol (PEG) was added to the reconstituted colloid. The reconstituted colloid was then ultrasonicated for 5 min to produce a cloudy gray solution. The reconstituted colloidal suspension was made to be 60 μm RB 15. FIG. 1B is a spectrum of this reconstituted colloidal suspension with RB 15 dye.
  • FIG. 2A represents a spectrum of a Partial Least Squares (PLS) correlation model obtained from running a concentration curve of a reconstituted colloid and RB 15 dye. A stock RB 15 solution was prepared by dissolving 0.01283 grams of RB 15 into 10 ml Millipore H[0035] 2O. Concentrations were prepared from the stock solution ranging from 1.0-6.18×10−6 M RB 15 using Millipore H2O. The reconstituted colloid (200 μL) was placed into separate 1 ml auto sampler vials. A 20 μL aliquot of each of the RB 15 concentrations was added to separate vials filled with reconstituted colloid. Each mixture was shaken for 20 sec to facilitate an even distribution of RB 15 dye in the colloid. A spectrum of each mixture was taken and recorded, after which PLS was performed on the data set. FIG. 2B shows the result in a correlation plot between actual concentration and predicted concentration with a R2=0.9793. This shows possibilities for lyophilized colloids. However, the lyophilized colloid is a very fine powder that is very susceptible to air currents. Accordingly, in the discussion which follows, polyethylene glycol (PEG) 900 will be introduced into the lyophilizing process to alleviate problems with containing the fine powder and preventing the lyophilized colloidal particles from sticking to the surface of a container.
  • FIG. 3A represents a spectrum of a PLS correlation model using 0.05% w/[0036] w PEG 900 m.w./colloid and RB 15 dye. In a 20 mL vial 0.200 g of PEG 900 was diluted to 4.00 g with colloid. A 370 μL Caraway blood collecting tube was submerged into liquid nitrogen until the nitrogen ceases to boil then 100 μL of the solution was injected into the frozen tube. Approximately 40 tubes can be prepared from 4.00 g of PEG 900/colloid solution. As shown in FIG. 3B, the tubes, denoted by numeral 30, were placed in a high vacuum vial 32 with a stopper 33 purchased from Labconco. The vial 32 and stopper 33 was placed in a Styrofoam cooler 34 packed in dry ice and attached to a lyophilizer (not shown), via a steel tube 36 which extends through the stopper, for 24 hours. A stock solution of 10.0×10−6 M RB 15 was prepared. A range of concentrations from 1.0-10.0×10−6 M RB 15 was prepared by diluting with Millipore H2O. In separate lyophilized tubes 100 μL of each concentration of RB 15 was injected and a 0.5×5 mm Teflon coated rod was inserted into each tube. A magnet was used to stir the solution with the rod until the lyophilized colloid was completely dissolved, this taking approximately 2 min. The solution was then allowed to flow to the narrow end of the blood collecting tube, a plug of Critoseal was inserted and the tube was placed, plug side down, into the Raman sample holder. A spectrum was taken and recorded for all the different concentrations, after which PLS was performed on the data set. FIG. 3C shows the result in a correlation plot between actual concentration and predicted concentration with a R2=0.9956. When the spectrum of FIG. 2A is compared to the spectrum of FIG. 3A, there are identical peaks and correlation. This indicates that the PEG has little effect on the Raman scattering and it aids in the containment of the lyophilized colloid eliminating susceptibility of the colloid powder to disruption by air currents and/or vibrations in a container. The PLS model from this experiment shows that PEG/colloidal solutions have great potential. Using this model, predictions of 40 samples at the same concentration (100 μL of 4.0×10−6 RB 15) were made to show reproducibility, i.e., STD=1.99; AVG=4.53; % Corr.=3.6%.
  • FIG. 4B shows a reagent of Analyte Reactive Coating soluble in Water (ARCW). Using this reagent in blood collecting tubes, a PLS model was made with bilirubin. FIG. 4A represents a spectrum of this PLS correlation model. The blood collecting tubes were prepared using the same procedure described above. In addition to lyophilizing the colloid in the tubes, 1 μL of 0.00299 M Diazonium ARCW was added to the opposite end from the colloid of each tube and also lyophilized. The tubes were then placed in a vacuum to remove the water from the colloid suspension and ARCW solution. A 2.99×10[0037] −4 M stock solution of bilirubin was prepared by dissolving 0.00175 g of bilirubin in a 5:4:1 ethanol, water, saturated bicarbonate solution. A 2.99×10−6 M solution of bilirubin was prepared by diluting with Millipore H2O, 100 μL of the stock solution to 9.8 mL H2O+100 μL 0.05 M KOH. A concentration range 5.98×10−7 to 2.99×10−6 M bilirubin was prepared. In the lyophilized tubes 100 μL of each concentration and a Teflon coated iron rod was added to the end of the tube, which contained the ARCW. This was allowed to set for 5 min, after which the solution was mixed with the colloid and a spectrum was taken. FIG. 4C shows the result for 0.05M KOH 100 μL in 9.8 mL H2O and 100 μL bilirubin, in a correlation plot between actual concentration and predicted concentration with a R2=0.9367.
  • FIG. 5 shows a PLS cross-validation plot of actual versus predicted human Growth Hormone (hGH) concentration levels for a Surface Enhanced Raman ImmunoAssay (SERIA) analysis using a lyophilized silver colloidal base. A Lee and Meisel silver colloidal suspension (R) was prepared to which was added a 1:400,000 dilution of polyclonal hGH antibody (Ab). This addition is accomplished by slowly adding small aliquots of the antibody solution (140 μL total) to 1 mL of the colloidal suspension with gentle agitation with continued mixing for 15 min. A stabilizer of polyethylene glycol (PEG, ave. 15000 MW) was added to the solution to make a 5% solution of PEG/RhGHAb. A mini-microwell plate (NUNC®) was used as the sample container for the analysis. To each of 10 wells of the plate was added 20 μL of the PEG/RhGHAb solution. The plate was placed in liquid nitrogen to ‘flash’ freeze the wells of solution and then placed in a high vacuum vial set in a cooling container of dry ice. The vacuum vial was then attached to the lyophilizer for 24 hr. Each well of lyophilized colloidal base appeared as a light tan colored waxy semi-solid. The addition of liquid immediately reconstituted the base to produce a light tan colored colloidal suspension resembling the original solution. The analysis was completed by the addition of varying concentration of hGH antigen in an aqueous sodium bicarbonate solution (1%), followed by the addition of a reporter molecule solution. The solution of antigen was used to reconstitute the lyophilized PEG/RhGHAb for the assay. [0038]
  • FIG. 6 shows a PLS cross-validation plot of actual versus predicted hGH concentration levels for a SERIA analysis similar to that described above. In this instance, the lyophilized colloidal base was a 0.5% PEG/RhGHAb. After lyophilization, the wells of colloidal base appeared as tan colored nugget with a puckered surface. Addition of the antigen solution caused complete reconstitution of the colloidal base. [0039]
  • While the foregoing invention has been described with reference to the above embodiments, various modifications and changes can be made without departing from the spirit of the invention. Accordingly, all such modifications and changes are considered to be within the scope of the appended claims. [0040]

Claims (63)

What is claimed is:
1. An assay for use in SERS spectroscopy, the assay comprising lyophilized colloidal particles of a metal, which when reconstituted, produce a SERS active solution.
2. The assay of claim 1, wherein the metal is a noble metal.
3. The assay of claim 1, wherein the assay is used in SERS spectroscopy to determine the concentration of an unknown solution.
4. The assay of claim 1, further comprising a material for preventing the particles from sticking to one another.
5. The assay of claim 4, wherein the material comprises a wax-like material.
6. The assay of claim 4, wherein the material comprises polyethylene glycol.
7. An assay system for use in SERS spectroscopy, the assay system comprising:
a container;
lyophilized colloidal particles of a metal disposed in a first section of the container;
wherein reconstitution of the lyophilized colloidal particles of a metal produce a SERS active solution.
8. The assay system of claim 7, wherein the metal is a noble metal.
9. The assay system of claim 7, further comprising a closure for sealing the container.
10. The assay system of claim 7, further comprising a reagent disposed in a second section of the container, the reagent for coupling an analyte to a SERS active metal.
11. The assay system of claim 10, wherein the second section of the container is remote from the first section of the container.
12. The assay system of claim 7, further comprising a material for preventing the particles from sticking to one another.
13. The assay system of claim 12, wherein the material comprises a wax-like material.
14. The assay system of claim 12, wherein the material comprises polyethylene glycol.
15. The assay system of claim 12, further comprising a pretreatment disposed on an inner surface of the container, the pretreatment for preventing the particles from sticking to one another and sticking to the inner surface of the container.
16. The assay system of claim 15, wherein the pretreatment comprises a wax-like material.
17. The assay system of claim 15, wherein the pretreatment comprises polyethylene glycol.
18. The assay system of claim 7, further comprising a pretreatment disposed on an inner surface of the container, the pretreatment for preventing the particles from sticking to one another and sticking to the inner surface of the container.
19. The assay system of claim 18, wherein the pretreatment comprises a wax-like material.
20. The assay system of claim 18, wherein the pretreatment comprises polyethylene glycol.
21. The assay system of claim 7, wherein the assay is used in SERS spectroscopy to determine the concentration of an unknown solution.
22. The assay system of claim 7, wherein the first section of the container includes a plurality of wells and lyophilized colloidal particles of a metal disposed in each of the wells.
23. The assay system of claim 22, wherein the lyophilized colloidal particles of metal include an antibody.
24. The assay system of claim 23, wherein the assay system forms a Surface Enhanced Raman ImmunoAssay.
25. A method of producing an assay for use in SERS spectroscopy, the method comprising:
providing a suspension of colloidal particles of metal;
lyophilizing the suspension of colloidal particles of metal to produce the assay, which when reconstituted, produce a SERS active solution.
26. The method of claim 25, wherein the metal is a noble metal.
27. The method of claim 25, further comprising the step of mixing the colloidal particles of metal with a material prior to the lyophilizing step, the material preventing the particles from sticking to one another.
28. The method of claim 27, wherein the material comprises a wax-like material.
29. The method of claim 27, wherein the material comprises polyethylene glycol.
30. A method of making an assay system for use in SERS spectroscopy, the method comprising the steps of:
providing a container;
placing a suspension of colloidal particles of a metal in a first section of the container;
lyophilizing the suspension of colloidal particles of the metal to produce an assay, which when reconstituted, produce a SERS active solution.
31. The method of claim 30, wherein the metal is a noble metal.
32. The method of claim 30, further comprising the step of mixing the suspension of colloidal particles of metal with a material prior to the placing step, the material preventing the particles from sticking to one another.
33. The method of claim 32, wherein the material comprises a wax-like material.
34. The method of claim 32, wherein the material comprises polyethylene glycol.
35. The method of claim 32, wherein the container providing step includes applying a pretreatment to an inner surface of the container, the pretreatment for preventing the particles from sticking to one another and sticking to the inner surface of the container.
36. The method of claim 35, wherein the pretreatment comprises a wax-like material.
37. The method of claim 35, wherein the pretreatment comprises polyethylene glycol.
38. The method of claim 30, further comprising the step of placing a reagent in a second section of the container, the reagent for coupling an analyte to a SERS active metal.
39. The method of claim 38, wherein the lyophilizing step further includes lyophilizing the reagent.
40. The method of claim 38, wherein the second section of the container is remote from the first section of the container.
41. The method of claim 30, where the container providing step includes applying a pretreatment to an inner surface of the container, the pretreatment for preventing the particles from sticking to one another and sticking to the inner surface of the container.
42. The method of claim 41, wherein the pretreatment comprises a wax-like material.
43. The method of claim 41, wherein the pretreatment comprises polyethylene glycol.
44. A method of analyzing a material, the method comprising the steps of:
providing a container;
placing a suspension of colloidal particles of a metal in a first section of the container;
lyophilizing the colloidal particles of the metal to produce an assay;
simultaneously reconstituting and mixing the assay with the material to be analyzed to produce a SERS active solution;
performing SERS spectroscopy on the SERS active solution.
45. The method of claim 44, wherein the metal is a noble metal.
46. The method of claim 44, further comprising the step of mixing the suspension of colloidal particles of metal with a material prior to the placing step, the material preventing the particles from sticking to one another.
47. The method of claim 46, wherein the material comprises a wax-like material.
48. The method of claim 46, wherein the material comprises polyethylene glycol.
49. The method of claim 46, wherein the container providing step includes applying a pretreatment to an inner surface of the container, the pretreatment for preventing the particles from sticking to one another and sticking to the inner surface of the container.
50. The method of claim 49, wherein the pretreatment comprises a wax-like material.
51. The method of claim 49, wherein the pretreatment comprises polyethylene glycol.
52. The method of claim 44, further comprising the step of placing a reagent in a second section of the container, the reagent for coupling an analyte to a SERS active metal.
53. The method of claim 52, wherein the lyophilizing step further includes lyophilizing the reagent.
54. The method of claim 52, wherein the second section of the container is remote from the first section of the container.
55. The method of claim 44, where the container providing step includes applying a pretreatment to an inner surface of the container, the pretreatment for preventing the particles from sticking to one another and sticking to the inner surface of the container.
56. The method of claim 55, wherein the pretreatment comprises a wax-like material.
57. The method of claim 55, wherein the pretreatment comprises polyethylene glycol.
58. The assay of claim 1, further comprising an antibody.
59. The assay system of claim 7, further comprising an antibody.
60. The method of claim 25, further comprising the step of mixing the suspension of colloidal particles of metal with an antibody prior to the lyophilizing step.
61. The method of claim 30, wherein the first section of the container includes a plurality of wells and lyophilized colloidal particles of a metal are placed in each of the wells.
62. The method of claim 61, wherein the lyophilized colloidal particles of metal include an antibody.
63. The method of claim 62, wherein the assay system forms a Surface Enhanced Raman ImmunoAssay.
US10/177,194 2001-06-21 2002-06-21 Lyophilization of colloidal metals for surface enhanced Raman scattering Abandoned US20030017620A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US10/177,194 US20030017620A1 (en) 2001-06-21 2002-06-21 Lyophilization of colloidal metals for surface enhanced Raman scattering
US13/160,985 US9097675B2 (en) 2001-06-21 2011-06-15 Lyophilization of colloidal metals for surface enhanced raman scattering

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30027001P 2001-06-21 2001-06-21
US10/177,194 US20030017620A1 (en) 2001-06-21 2002-06-21 Lyophilization of colloidal metals for surface enhanced Raman scattering

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/160,985 Division US9097675B2 (en) 2001-06-21 2011-06-15 Lyophilization of colloidal metals for surface enhanced raman scattering

Publications (1)

Publication Number Publication Date
US20030017620A1 true US20030017620A1 (en) 2003-01-23

Family

ID=26873026

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/177,194 Abandoned US20030017620A1 (en) 2001-06-21 2002-06-21 Lyophilization of colloidal metals for surface enhanced Raman scattering
US13/160,985 Expired - Fee Related US9097675B2 (en) 2001-06-21 2011-06-15 Lyophilization of colloidal metals for surface enhanced raman scattering

Family Applications After (1)

Application Number Title Priority Date Filing Date
US13/160,985 Expired - Fee Related US9097675B2 (en) 2001-06-21 2011-06-15 Lyophilization of colloidal metals for surface enhanced raman scattering

Country Status (1)

Country Link
US (2) US20030017620A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100291701A1 (en) * 2004-05-06 2010-11-18 University Of Wyoming Cyanide and related species detection with metal surfaces
USD731672S1 (en) 2012-04-12 2015-06-09 Becton, Dickinson And Company Vessel assembly
US9494581B2 (en) 2004-08-24 2016-11-15 University Of Wyoming System and method for Raman spectroscopy assay using paramagnetic particles

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110575781B (en) * 2014-06-18 2022-07-29 卢米耐克斯公司 Apparatus and method for magnetic mixing

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3799742A (en) * 1971-12-20 1974-03-26 C Coleman Miniaturized integrated analytical test container
US4043678A (en) * 1976-03-01 1977-08-23 Technicon Instruments Corporation Cuvette
US4450231A (en) * 1982-03-31 1984-05-22 Biostar Medical Products, Inc. Immunoassay for determination of immune complexes with polymer-coated plastic base
US4920061A (en) * 1984-03-02 1990-04-24 The University Of Texas System Biological magnetic colloids
US4980286A (en) * 1985-07-05 1990-12-25 Whitehead Institute For Biomedical Research In vivo introduction and expression of foreign genetic material in epithelial cells
US5102788A (en) * 1988-11-21 1992-04-07 Hygeia Sciences, Inc. Immunoassay including lyophilized reactant mixture
US5169789A (en) * 1986-12-03 1992-12-08 New Horizons Diagnostics Corporation Device and method for self contained solid phase immunodiffusion assay
US5252459A (en) * 1988-09-23 1993-10-12 Abbott Laboratories Indicator reagents, diagnostic assays and test kits employing organic polymer latex particles
US5283173A (en) * 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions
US5637508A (en) * 1993-03-26 1997-06-10 Geo-Centers, Inc. Biomolecules bound to polymer or copolymer coated catalytic inorganic particles, immunoassays using the same and kits containing the same
US5705207A (en) * 1995-05-02 1998-01-06 Opta Food Ingredients, Inc. Method of making gluten colloidal dispersions and edible coatings therefrom
US5759774A (en) * 1988-05-18 1998-06-02 Cobe Laboratories, Inc. Method of detecting circulating antibody types using dried or lyophilized cells
US6391652B2 (en) * 1997-08-07 2002-05-21 Nitto Denko Corporation Immunoassay method and immunoassay kit
US6770488B1 (en) * 1999-03-19 2004-08-03 The University Of Wyoming Practical method and apparatus for analyte detection with colloidal particles

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376556A (en) * 1989-10-27 1994-12-27 Abbott Laboratories Surface-enhanced Raman spectroscopy immunoassay
US5255067A (en) 1990-11-30 1993-10-19 Eic Laboratories, Inc. Substrate and apparatus for surface enhanced Raman spectroscopy
JPH07146295A (en) * 1993-11-19 1995-06-06 Kyoto Daiichi Kagaku:Kk Immunoanalysis method and device by raman spectral measurement
WO1998059234A1 (en) 1997-06-24 1998-12-30 The University Of Wyoming Method and apparatus for detection of a controlled substance
US6989897B2 (en) 2002-06-12 2006-01-24 Intel Corporation Metal coated nanocrystalline silicon as an active surface enhanced Raman spectroscopy (SERS) substrate
US6970239B2 (en) 2002-06-12 2005-11-29 Intel Corporation Metal coated nanocrystalline silicon as an active surface enhanced Raman spectroscopy (SERS) substrate
US7776610B2 (en) 2003-05-07 2010-08-17 University Of Wyoming Cyanide and related species detection with metal surfaces
US7993933B2 (en) 2004-05-06 2011-08-09 University Of Wyoming Cyanide and related species detection with metal surfaces

Patent Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3799742A (en) * 1971-12-20 1974-03-26 C Coleman Miniaturized integrated analytical test container
US4043678A (en) * 1976-03-01 1977-08-23 Technicon Instruments Corporation Cuvette
US4450231A (en) * 1982-03-31 1984-05-22 Biostar Medical Products, Inc. Immunoassay for determination of immune complexes with polymer-coated plastic base
US4920061A (en) * 1984-03-02 1990-04-24 The University Of Texas System Biological magnetic colloids
US4980286A (en) * 1985-07-05 1990-12-25 Whitehead Institute For Biomedical Research In vivo introduction and expression of foreign genetic material in epithelial cells
US5169789A (en) * 1986-12-03 1992-12-08 New Horizons Diagnostics Corporation Device and method for self contained solid phase immunodiffusion assay
US5759774A (en) * 1988-05-18 1998-06-02 Cobe Laboratories, Inc. Method of detecting circulating antibody types using dried or lyophilized cells
US5252459A (en) * 1988-09-23 1993-10-12 Abbott Laboratories Indicator reagents, diagnostic assays and test kits employing organic polymer latex particles
US5102788A (en) * 1988-11-21 1992-04-07 Hygeia Sciences, Inc. Immunoassay including lyophilized reactant mixture
US5283173A (en) * 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions
US5667973A (en) * 1990-01-24 1997-09-16 The Research Foundation Of State University Of New York System to detect protein-protein interactions
US5468614A (en) * 1990-01-24 1995-11-21 The Research Foundation Of State University Of New York System to detect protein-protein interactions
US5637508A (en) * 1993-03-26 1997-06-10 Geo-Centers, Inc. Biomolecules bound to polymer or copolymer coated catalytic inorganic particles, immunoassays using the same and kits containing the same
US5705207A (en) * 1995-05-02 1998-01-06 Opta Food Ingredients, Inc. Method of making gluten colloidal dispersions and edible coatings therefrom
US6391652B2 (en) * 1997-08-07 2002-05-21 Nitto Denko Corporation Immunoassay method and immunoassay kit
US6770488B1 (en) * 1999-03-19 2004-08-03 The University Of Wyoming Practical method and apparatus for analyte detection with colloidal particles

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100291701A1 (en) * 2004-05-06 2010-11-18 University Of Wyoming Cyanide and related species detection with metal surfaces
US7993933B2 (en) 2004-05-06 2011-08-09 University Of Wyoming Cyanide and related species detection with metal surfaces
US9494581B2 (en) 2004-08-24 2016-11-15 University Of Wyoming System and method for Raman spectroscopy assay using paramagnetic particles
USD731672S1 (en) 2012-04-12 2015-06-09 Becton, Dickinson And Company Vessel assembly
USD773683S1 (en) 2012-04-12 2016-12-06 Becton, Dickinson And Company Vessel
USD796687S1 (en) 2012-04-12 2017-09-05 Becton, Dickinson And Company Basket
USD881408S1 (en) 2012-04-12 2020-04-14 Becton, Dickinson And Company Cap
USD932049S1 (en) 2012-04-12 2021-09-28 Becton, Dickinson And Company Vessel assembly

Also Published As

Publication number Publication date
US20110294230A1 (en) 2011-12-01
US9097675B2 (en) 2015-08-04

Similar Documents

Publication Publication Date Title
Zhang et al. Surface-enhanced Raman spectroscopy (SERS) combined techniques for high-performance detection and characterization
DE2548427C2 (en) Apparatus for use in solid phase immunoassay of a component of an antigen-antibody reaction and a method for its preparation
EP0969279B1 (en) Fluorescence polarization method at multiple wavelengths
JP4532121B2 (en) Highly sensitive immunochromatographic assay
CN100501403C (en) Method for detecting analyte(s) using magnetic colloidal particles
US7659086B2 (en) Immunoassay employing two-step internal calibration reaction
US9618454B2 (en) Method of identifying a material
KR20030040208A (en) Improvements to the fluorescent polymer-QTL approach to biosensing
EP0240021A1 (en) Fluorescence polarization immunoassay and reagents for use therein
EP1894007A1 (en) Method and device for the quantitative determination of analytes in liquid samples
US9097675B2 (en) Lyophilization of colloidal metals for surface enhanced raman scattering
US20090311724A1 (en) Use of additives for the reduction of non-specific binding in assays
US20140287527A1 (en) Method and apparatus for time-resolved fluorescence immunoassay testing
KR960029789A (en) Kits for immunological analysis of in vivo substances and immunological analysis methods
JP2009506319A (en) Multifaceted immunochromatographic assay
US7799579B2 (en) Method and device for processing a biological fluid for analyte determination
GB2065298A (en) Method and Apparatus for Detecting Biological Particles by Induced Signal
EP1204856A1 (en) Method for the determination of substances using the evanescence field method
US5633140A (en) Reaction vessel for immunological analysis of aerosols
Kumar et al. Bioconjugation of anti estrogen alpha antibody with CdSSe/ZnS quantum dots for molecular sensing of a breast cancer antigen
EP3116650B1 (en) Method and device for the determination of biological analytes
Pulido-Tofiño et al. Sol–gel glass doped with isoproturon antibody as selective support for the development of a flow-through fluoroimmunosensor
WO2000062061A1 (en) Device and method for use in receptor-ligand and affinity tests
CN107656062A (en) A kind of method using nanoparticle time-resolved fluorescence probe in detecting chloramphenicol
CN111537751A (en) Myocardial troponin I, creatine kinase isoenzyme and myoglobin joint detection kit and detection method

Legal Events

Date Code Title Description
AS Assignment

Owner name: WYOMING, UNIVERSITY OF, WYOMING

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CARRON, KEITH T.;RAY, BRYAN HUBERT;SULK, ROBERTA A.;AND OTHERS;REEL/FRAME:013567/0885;SIGNING DATES FROM 20020926 TO 20020927

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION